Therapeutic efficacy of antitumor monoclonal antibodies combined with chemotherapy depends on innate immunity and NK1.1-innate lymphoid cells Meeting Abstract

  

Authors:	Moskalenko, M.; Pan, M.; Hashimoto, D.; Mortha, A.; Bernardo, S. G.; Leboeuf, M.; Houghton, A.; Wolchok, J.; Burakoff, S.; Merad, M.; Saenger, Y. M.
Abstract Title:	Therapeutic efficacy of antitumor monoclonal antibodies combined with chemotherapy depends on innate immunity and NK1.1-innate lymphoid cells
Meeting Title:	American Association for Cancer Research (AACR) Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances
Journal Title:	Cancer Research
Volume:	73
Issue:	1 Suppl.
Meeting Dates:	2012 Dec 2-5
Meeting Location:	Miami, FL
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2013-01-01
Language:	English
ACCESSION:	WOS:000209496300023
DOI:	10.1158/1538-7445.tumimm2012-a43
PROVIDER:	wos
Notes:	Meeting Abstract: A43 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/99297